4.0 Editorial Material

Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases

Journal

MOLECULAR INTERVENTIONS
Volume 10, Issue 5, Pages 263-270

Publisher

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mi.10.5.3

Keywords

-

Funding

  1. NCCIH NIH HHS [R21 AT003633, AT-003633] Funding Source: Medline
  2. NIAMS NIH HHS [R03 AR055741, AR-055741] Funding Source: Medline
  3. NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003633] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055741] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available